BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33491944)

  • 1. Overexpression of the TRIM24 E3 Ubiquitin Ligase is Linked to Genetic Instability and Predicts Unfavorable Prognosis in Prostate Cancer.
    Höflmayer D; Fraune C; Hube-Magg C; Simon R; Schroeder C; Büscheck F; Möller K; Dum D; Weidemann S; Wittmer C; Schlomm T; Huland H; Heinzer H; Graefen M; Haese A; Sauter G; Burandt E; Clauditz TS; Steurer S; Minner S; Wilczak W; Polonski A
    Appl Immunohistochem Mol Morphol; 2021 Apr; 29(4):e29-e38. PubMed ID: 33491944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM24 as an independent prognostic biomarker for prostate cancer.
    Offermann A; Roth D; Hupe MC; Hohensteiner S; Becker F; Joerg V; Carlsson J; Kuempers C; Ribbat-Idel J; Tharun L; Sailer V; Kirfel J; Svensson M; Andren O; Lubczyk V; Kuefer R; Merseburger AS; Perner S
    Urol Oncol; 2019 Sep; 37(9):576.e1-576.e10. PubMed ID: 31178279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers.
    Grupp K; Sanader S; Sirma H; Simon R; Koop C; Prien K; Hube-Magg C; Salomon G; Graefen M; Heinzer H; Minner S; Izbicki JR; Sauter G; Schlomm T; Tsourlakis MC
    Mol Oncol; 2013 Dec; 7(6):1001-11. PubMed ID: 23941784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulated circular RNA itchy E3 ubiquitin protein ligase correlates with advanced pathologic T stage, high lymph node metastasis risk and poor survivals in prostate cancer patients.
    Huang E; Chen X; Yuan Y
    Cancer Biomark; 2019; 26(1):41-50. PubMed ID: 31306101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of TRIM24 Stimulates Proliferation and Glucose Metabolism of Head and Neck Squamous Cell Carcinoma.
    Wang H; Xue W; Jiang X
    Biomed Res Int; 2018; 2018():6142843. PubMed ID: 29862279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic relevance of tripartite motif containing 24 expression in colorectal cancer.
    Wang FQ; Han Y; Yao W; Yu J
    Pathol Res Pract; 2017 Oct; 213(10):1271-1275. PubMed ID: 28916426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer.
    Burdelski C; Reiswich V; Hube-Magg C; Kluth M; Minner S; Koop C; Graefen M; Heinzer H; Tsourlakis MC; Wittmer C; Huland H; Simon R; Schlomm T; Sauter G; Steurer S
    Clin Cancer Res; 2015 Aug; 21(15):3471-9. PubMed ID: 25925890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM24 promotes glioma progression and enhances chemoresistance through activation of the PI3K/Akt signaling pathway.
    Zhang LH; Yin AA; Cheng JX; Huang HY; Li XM; Zhang YQ; Han N; Zhang X
    Oncogene; 2015 Jan; 34(5):600-10. PubMed ID: 24469053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance and prognostic value of TRIM24 expression in esophageal squamous cell carcinoma.
    Chi J; Yang Q; Xie XF; Yang XZ; Zhang MY; Wang HY; Xu GL
    Aging (Albany NY); 2016 Sep; 8(9):2204-2221. PubMed ID: 27689360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancer.
    Jacobsen F; Taskin B; Melling N; Sauer C; Wittmer C; Hube-Magg C; Kluth M; Simon R; Pehrke D; Beyer B; Steuber T; Thederan I; Sauter G; Schlomm T; Wilczak W; Möller K; Weidemann SA; Burdak-Rothkamm S
    BMC Cancer; 2017 Jul; 17(1):504. PubMed ID: 28747165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance and biological roles of TRIM24 in human bladder carcinoma.
    Xue D; Zhang X; Zhang X; Liu J; Li N; Liu C; Liu Y; Wang P
    Tumour Biol; 2015 Sep; 36(9):6849-55. PubMed ID: 25846736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIM24 overexpression is common in locally advanced head and neck squamous cell carcinoma and correlates with aggressive malignant phenotypes.
    Cui Z; Cao W; Li J; Song X; Mao L; Chen W
    PLoS One; 2013; 8(5):e63887. PubMed ID: 23717505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM28 protects TRIM24 from SPOP-mediated degradation and promotes prostate cancer progression.
    Fong KW; Zhao JC; Song B; Zheng B; Yu J
    Nat Commun; 2018 Nov; 9(1):5007. PubMed ID: 30479348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of TRIM24/TIF-1α gene expression in breast cancer.
    Chambon M; Orsetti B; Berthe ML; Bascoul-Mollevi C; Rodriguez C; Duong V; Gleizes M; Thénot S; Bibeau F; Theillet C; Cavaillès V
    Am J Pathol; 2011 Apr; 178(4):1461-9. PubMed ID: 21435435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer.
    Groner AC; Cato L; de Tribolet-Hardy J; Bernasocchi T; Janouskova H; Melchers D; Houtman R; Cato ACB; Tschopp P; Gu L; Corsinotti A; Zhong Q; Fankhauser C; Fritz C; Poyet C; Wagner U; Guo T; Aebersold R; Garraway LA; Wild PJ; Theurillat JP; Brown M
    Cancer Cell; 2016 Jun; 29(6):846-858. PubMed ID: 27238081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of tripartite motif containing 24 in various human solid malignant neoplasms: An updated meta-analysis and systematic review.
    Xue Y; Ge W; Shi W; Huang W; Wang R
    Medicine (Baltimore); 2021 Dec; 100(51):e28383. PubMed ID: 34941167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer.
    Wilczak W; Rashed S; Hube-Magg C; Kluth M; Simon R; Büscheck F; Clauditz TS; Grupp K; Minner S; Tsourlakis MC; Möller-Koop C; Graefen M; Adam M; Haese A; Wittmer C; Sauter G; Izbicki JR; Huland H; Schlomm T; Steurer S; Krech T; Lebok P
    Carcinogenesis; 2017 Jan; 38(1):19-27. PubMed ID: 27803051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion.
    Fraune C; Harms L; Büscheck F; Höflmayer D; Tsourlakis MC; Clauditz TS; Simon R; Möller K; Luebke AM; Möller-Koop C; Steurer S; Hube-Magg C; Sauter G; Weidemann S; Lebok P; Dum D; Kind S; Minner S; Izbicki JR; Schlomm T; Huland H; Heinzer H; Burandt E; Haese A; Graefen M; Schroeder C
    Mol Med; 2020 Mar; 26(1):24. PubMed ID: 32143573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of gene expression in human cancers by TRIM24.
    Appikonda S; Thakkar KN; Barton MC
    Drug Discov Today Technol; 2016 Mar; 19():57-63. PubMed ID: 27769359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancer.
    Burdelski C; Ruge OM; Melling N; Koop C; Simon R; Steurer S; Sauter G; Kluth M; Hube-Magg C; Minner S; Wittmer C; Wilczak W; Hinsch A; Lebok P; Izbicki JR; Heinzer H; Graefen M; Huland H; Schlomm T; Krech T
    Exp Mol Pathol; 2015 Jun; 98(3):419-26. PubMed ID: 25794974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.